Home - Products - Others - Other Targets - 1,3,8-Trihydroxy-7-methoxyxanthone

1,3,8-Trihydroxy-7-methoxyxanthone

CAS No. 5042-15-9

1,3,8-Trihydroxy-7-methoxyxanthone( ——— )

Catalog No. M38765 CAS No. 5042-15-9

1,3,8-Trihydroxy-7-methoxyxanthone

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1,3,8-Trihydroxy-7-methoxyxanthone
  • Note
    Research use only, not for human use.
  • Brief Description
    1,3,8-Trihydroxy-7-methoxyxanthone
  • Description
    1,3,8-Trihydroxy-7-methoxyxanthone
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    5042-15-9
  • Formula Weight
    274.22
  • Molecular Formula
    C14H10O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 5-methoxydeydrodiiso...

    Maceneolignan A is a natural product that can be isolated from mace, the aril of Myristica fragrans (Myristicaceae). Maceneolignan A inhibits the release of β-hexosaminidase in RBL-2H3 cells, with an IC50 of 48.4 μM. Maceneolignan A inhibits the release of TNF-α in antigen stimulated RBL-2H3 cells, with an IC50 of 63.7 μM.

  • Boc-NH-PEG7-Tos

    Boc-NH-PEG7-Tos is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Nemorubicin

    Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?